RE: Frustrated27 Mar 2026 19:30
When asked why the company did not releases more RNS about developments we find out about informally, by trawling patent websites and following LinkedIn etc, JS replied that they only posted RNS which had a materially impact on their current financial position. I understand his view but I disagree with it. A RNS can be used to talk about developments which help generate interest in small fast growing companies such as Itaconix. I do hope they will reconsider this but suspect they won’t as they seem rather stuck in their ways.
@Arkham, in light of this, you may be correct about the share price trading sideways for some time as we already know from the broker forecasts the estimated revenue and EBITDA position for 2026, so upcoming trading updates just reiterate the company is expanding as planned. That’s fine but it’s not going to generate the excitement which we all crave. Long term they are an excellent investment, and I will keep ploughing money into my ISA at these prices, but I agree it may take some time to see the multibagger returns we are all aiming for.